MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 07.05.2026
Senseonics Holdings Operativer Cashflow 2011-2026 | SENS
Operativer Cashflow Jährlich Senseonics Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -59.1 M | -60.5 M | -70.2 M | -66.3 M | -56.1 M | -67.4 M | -136 M | -90.8 M | -55.7 M | -38 M | -25.5 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -25.5 M | -136 M | -66 M |
Operativer Cashflow Vierteljährlich Senseonics Holdings
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32 M | - | - | -16.1 M | - | - | - | -20.3 M | - | - | - | -19.8 M | - | -48.9 M | -34.3 M | -20.2 M | - | -44.3 M | -30.4 M | -16.3 M | - | -59.2 M | -45.8 M | -29 M | - | -101 M | -65.9 M | -30.2 M | - | -67.1 M | -40.4 M | -20.5 M | - | -39.4 M | -24.2 M | -11.6 M | - | -27.8 M | -17.4 M | - | - | -8.19 K | - | - | - | -5.58 K | -7.81 K | -5.58 K | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -5.58 K | -101 M | -30.8 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 197.76 | -1.61 % | $ 22 B | USA |
 |
Celcuity
CELC
|
-153 M | $ 88.05 | 0.84 % | $ 4.12 B | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 3.33 | -13.28 % | $ 4.43 M | USA |
 |
Fulgent Genetics
FLGT
|
-102 M | $ 17.7 | -1.61 % | $ 545 M | USA |
 |
Castle Biosciences
CSTL
|
64.3 M | $ 20.25 | -1.03 % | $ 587 M | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-24.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
-185 M | $ 129.11 | 1.39 % | $ 16.2 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.65 | 4.78 % | $ 7.3 M | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 23.48 | 0.99 % | $ 1.25 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Illumina
ILMN
|
1.08 B | $ 159.09 | -3.16 % | $ 24.7 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
1.04 B | $ 143.27 | -0.19 % | $ 11.2 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-9.68 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-460 M | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
26.4 M | $ 17.75 | -3.9 % | $ 397 M | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 103.19 | -1.75 % | $ 6.96 B | USA |
 |
Natera
NTRA
|
215 M | $ 226.44 | 2.88 % | $ 31 B | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 182.34 | -1.33 % | $ 9.04 B | USA |
 |
Pacific Biosciences of California
PACB
|
-111 M | $ 1.34 | -0.74 % | $ 402 M | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 457.09 | -0.98 % | $ 13.2 B | USA |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 129.53 | -1.91 % | $ 23.3 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 10.38 | -1.05 % | $ 1.33 B | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.38 | 3.06 % | $ 406 M | USA |
 |
Personalis
PSNL
|
-74.9 M | $ 9.75 | 0.62 % | $ 870 M | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
46.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 1.97 | 2.07 % | $ 4.53 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 82.87 | -2.45 % | $ 4.96 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 259.56 | -2.03 % | $ 21.6 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.82 B | $ 461.69 | -2.31 % | $ 174 B | USA |
 |
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.58 | 1.74 % | $ 208 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 8.93 | -4.08 % | $ 1.94 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |